Diazepam Gel
Product Images NDC 68682-652

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Diazepam (NDC 68682-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Callforhelp.jpg (Callforhelp)

This is a set of instructions in case of a medical emergency related to seizures. The text lists different scenarios in which immediate help should be requested, including seizures that persist for more than 15 minutes despite medication, changes in seizure behavior, alarmingly frequent or severe seizures, or unusual breathing or color changes in the person having the seizure. The text also provides emergency contact information for both local emergency services and the individual's doctor, as well as information regarding the dose and time of Diazepam Rectal Gel administered.*

FDA Label Image

Figure 7 (Diastat Figure 07)

This text is a simple set of instructions for confirming the visibility of the dose and the green "READY" band in a dose display window. It is likely referring to a medical device or equipment.*

FDA Label Image

Figure1.jpg (Figure1)

This is a graph displaying the mean plasma concentration in ng/mL of Diazepam and Desmethyldiazepam over a period of 20 hours after being administered either 7.5mg IV or 15mg of Diazepam rectal gel. The X-axis represents the time in hours, while the Y-axis represents the concentration. The concentration levels of Diazepam and Desmethyldiazepam are shown in green and purple curves, respectively.*

FDA Label Image

Figure2.jpg (Figure2)

This is a graph displaying the results of a study on Diazepam Rectal Gel compared to a Placebo. The graph shows the percentage of patients who reported if they felt worse, the same, or better after using the product. There is no other available information.*

FDA Label Image

Figure3.jpg (Figure3)

This is not-available as the provided text is incomplete and does not offer any useful information.*

FDA Label Image

Figure4.jpg (Figure4)

This is a graph showing the time (in hours) of the effect of Diazepam Rectal Gel and Placebo. The graph has no significant data on it, just the labeling of the drugs and the time axis.*

FDA Label Image

Firststeps.jpg (Firststeps)

This text provides instructions on how to put a person on their side where they cannot fall, and also includes instructions on how to use a syringe and lubricate a rectal tip. There is also a reference to a plunger, but it is unclear how it fits into the instructions provided.*

FDA Label Image

Chemical Structure (Image 01)

FDA Label Image

Callforhelp (Image 02)

This text provides information on where to find more support and information related to Diazepam Rectal Gel, including a contact number (1-877-361-2719) for additional information on the delivery system. It also mentions the Epilepsy Foundation (EF) as a resource, with a phone number (1-800-EFA-1000) and website (www.efa.org) for those seeking further assistance.*

FDA Label Image

Image 03

This is a prescription-only Diazepam rectal gel delivery system intended for rectal administration only. The package contains the prescription label and prescription information. The lot number and expiration date are printed on the packaging, and the package insert contains information about prescribing. The gel should be stored at 25°C (77°F) and can be permitted to a temperature range of 15°C to 30°C (59°F to 86°F). The packaging warns users not to cover the window with a label and keep it out of reach of children. This product was distributed by Oceanside Pharmaceuticals and manufactured by DPT Laboratories in San Antonio, Texas, in 2019.*

FDA Label Image

Image 04

This is a prescription-only rectal gel medication called Diazepam used for rectal administration. The medication comes in a 20mg delivery system, and users must refer to the package insert for prescribing information. The lot number and expiration date must also be checked before use. The medication should not be covered, and it must be kept out of children's reach. The medication should be stored at 25°C, with excursions allowed for 15° to 30°C. The medication is distributed by Oceanide Rammacesicls, and the dose and administration are determined by licensed health practitioners. The medication is manufactured by DFT Laborstories, Ltd in San Antonio, Texas. Information on Bausch Health Companies can be found on the prescription label.*

FDA Label Image

Image 05

Diazepam Rectal Gel is a prescription medication administered rectally for the treatment of certain medical conditions. It comes in a container with NDC 68682-650-20 and contains 2.5 mg of diazepam per dose. The medication is to be used only as recommended in the package insert or as directed by your healthcare provider. The medication should be stored at a temperature of 25°C (77°F) and kept out of reach of children. The product is distributed by Oceanside Pharmaceuticals, which is a division of a company called St. lvmyymlin. The medication is manufactured by DPT Laboratories, Ltd 9570101, located in San Antonio, TX 78215 USA.*

FDA Label Image

Image 06

This is a prescription drug called Diazepam Rectal Gel. It is a 10mg delivery system that comes with two prefilled, adjustable dose syringes for rectal delivery along with lubricating jelly and instructions for use. The product should not be dispensed until both syringes have been dialed and locked. The pharmacist should instruct caregivers and patients to confirm that the correct dose has been dialed and review instructions prior to dispensing. The prescribed dose should be dialed and locked on the front panel after following the instructions on the back of the card. The drug comes with a lot/exp. and seriali number.*

FDA Label Image

Image 07

This is a description of medication called Diazepam Rectal Gel intended for rectal delivery. The pack includes two prefilled syringes with lubricating jelly for administration and instructions for use. The pharmacist is required to dial and lock the correct dose before dispensing the medication and the prescription label is not to be placed until the process is completed. Containing 125 ms, 175 ms, and 20 mg doses, the medication is only available through prescription.*

FDA Label Image

Image 08

This is a set of instructions for pharmacists regarding the administration of Diazepam Rectal Gel via syringe. The instructions involve selecting the correct dose, adjusting the syringe, and locking it into place before the medication is administered. The instructions emphasize the importance of confirming the correct dose before leaving the pharmacy. Contact information for questions is provided.*

FDA Label Image

Secondsteps.jpg (Secondsteps)

This document provides instructions for administering and disposing of Diazepam Rectal Gel. The user is instructed to insert the syringe tip into the rectum and press the plunger until it stops before slowly removing the syringe. Disposal instructions are provided for both the gel and the syringe after use. Users are advised to discard all used materials in the garbage can and away from children. Details are provided for Diazepam Rectal Gel 10 mg and 20 mg delivery systems.*

FDA Label Image

Telldoctor.jpg (Telldoctor)

This appears to be a medical document tracking the number and type of seizures a patient experiences before and after using Diazepam Rectal Gel. It includes columns for "Date," "Seizures Before Diazepam Rectal Gel" (with subcolumns for "Seizure No.", "Time" and "Type"), and "Seizures After Diazepam Rectal Gel" (also with subcolumns for "Seizure No.", "Time" and "Type").*

FDA Label Image

Treatment2.jpg (Treatment2)

This text appears to be a table containing information about seizures before and after the use of Diazepam Rectal Gel. There are columns for the date, seizure number, type of seizure, and the number of seizures before and after the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.